Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Innovative Research Reagents for Inflammation & Immune Responses
Toggle Nav
New Products Archive |
|
Latest Product Highlights ArchiveNew & Potent DYRK/CLK Inhibitors for Alzheimer's Research
|
News & Press ReleasesAbcalis and AdipoGen Life Sciences Partner on Distributing Animal-free Recombinant Monoclonal and Multiclonal Antibodies on the Life Science Research Market Roles of mouse BCMA, TACI, BAFF & APRIL in supporting Antibody-producing Cells A recent study published in PNAS reported that BAFF and APRIL contribute to maintaining IgG, IgA, and IgM plasma cells in the bone marrow (BM), spleen and intestine and rely mainly on three ligand/receptor pairs: APRIL-BCMA, BAFF-TACI, and APRIL-TACI. To efficiently target plasma cells, dual inhibition of BAFF and APRIL using blocking antibodies developed at AdipoGen Life Sciences is required. |
Collaborating with |
|